Lysis:Article Title: mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction.
Article Snippet: LC3 puncta intensity per cell was quantified using the Zeiss ZenBlue 3.3 analysis suite. .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741). .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741).
Protease Inhibitor:Article Title: mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction.
Article Snippet: LC3 puncta intensity per cell was quantified using the Zeiss ZenBlue 3.3 analysis suite. .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741). .. Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each.Western blots were performed using the following antibodies purchased fromCell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741).
other:
Western Blot:Article Title: mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction
Article Snippet: Cells were lysed using lysis buffer containing 20 mM Tris pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 50 mM NaF, 1 mM DTT, with protease inhibitor cocktail (Sigma #P8340), phosphatase inhibitor cocktail #2 (Sigma #P5726), and #3 (Sigma #P0044) used at 1:100 each. .. Western blots were performed using the following antibodies purchased from Cell Signaling Technology and used at 1:1000 dilution unless otherwise indicated: phospho-p70 S6 Kinase T389 (CST #9234 1:2000), p70 S6 Kinase (CST #2708, 1:2500), phospho-4E-BP1 T37/46 (CST #2855), 4E-BP1 (CST #9644, 1:5000), phospho-ULK1 S757 (CST #14202), ULK1 (CST #8054), phospho-S6 S235/236 (CST #4858 1:5000), phospho-S6 S240/244 (CST #5364 1:5000), S6 (CST #2317), Cyclin E1 (CST #20808), Cyclin A2 (CST #4656), Cyclin B1 (CST #4138), Cyclin D2 (CST #3741), Cyclin E2 (CST #4132), phospho-TSC2 T1462 (CST #3617), phospho-GSK3 S9/21 (CST #9331), TSC2 (CST #4308), GAPDH (CST #5174, 1:5000), phospho-Akt T308 (CST #13038), phospho-Akt S473 (CST #4060 1:5000), Akt (CST #4691), phospho-Erk Y202/204 (CST #9106), Erk (CST #9102), phospho-Wee1 S642 (CST #4910), Wee1 (CST #13084), phospho-CDK1 Y15 (CST #4539), CDK1 (CST #9116), phospho-Chk1 S345 (CST #2348), phospho-Chk1 S296 (CST #90178), Chk1 (CST #2360), LC3 A/B (CST #12741). ..
|